RadNet reports record growth in Q4 and full year 2025, showcasing strong financial performance and strategic AI acquisition with Gleamer.

RadNet delivered impressive financial results for the fourth quarter and the full year of 2025, showcasing robust growth across its imaging and digital health segments. The company's revenue soared by 14.8% to $547.7 million, while adjusted EBITDA increased by 16.9% to $87.7 million. With the announcement of the acquisition of Gleamer, a Paris-based radiology AI company, RadNet is well-positioned for continued expansion and innovation in the healthcare imaging sector.

Financial Performance

RadNet's fourth quarter demonstrated significant financial strength, driven by a combination of increased procedural volume and strategic investments. Key financial metrics included:

• Total Revenue: $547.7 million, up 14.8% year-over-year
• Adjusted EBITDA: $87.7 million, up 16.9% from the same quarter last year
• Digital Health Segment Performance: Revenue for the digital health division surged by 48.2% to $27.9 million, with adjusted EBITDA rising 8.9% to $4.9 million.

The strong performance can be attributed to a 14.1% aggregate growth in advanced imaging procedural volumes and a 9.6% increase in same-center volumes. Advanced imaging, which includes MRI, CT, and PET CT, accounted for over 60% of the company's revenue, highlighting its importance to RadNet's profitability.

During 2025, RadNet opened seven new facilities, enhancing its capacity and market reach. The total number of imaging centers grew to 418, with 36.1% held within health system partnerships, signaling the company's commitment to expanding its footprint in outpatient imaging.

Strategic Initiatives

RadNet's strategic initiatives are centered around enhancing its service offerings and operational efficiency through acquisitions and advanced technology integration. The acquisition of Gleamer is a pivotal move in this direction, as it positions RadNet as the largest provider of radiology clinical AI solutions worldwide. Key strategic highlights include:

• Acquisition of Gleamer: The integration of Gleamer's AI capabilities into RadNet's existing digital health platform will enhance workflow efficiency and diagnostic accuracy across its imaging centers.
• Investment in Advanced Imaging: The company has made significant investments in advanced imaging equipment, underpinning its commitment to improve service quality and patient outcomes through cutting-edge technology.
• Expansion of Joint Ventures: RadNet expanded its partnerships with health systems, recognizing the need for cost-effective outpatient imaging solutions. These collaborations are essential for driving procedural volume growth and enhancing the company's market positioning.

Furthermore, RadNet is focused on addressing labor shortages in the healthcare sector through AI-driven solutions. The company believes that AI will play a critical role in optimizing labor efficiency and improving patient care within its facilities.

Future Outlook

Looking ahead, RadNet's management is optimistic about its growth trajectory. The company has provided guidance for 2026, which anticipates:

• Imaging Center Revenue Growth: 17% to 19% growth driven by new acquisitions, improved same-center performance, and favorable reimbursement trends.
• EBITDA Growth: Expected to outpace revenue growth, leading to improved margins.
• Free Cash Flow Growth: Projected to increase by 29% to 41% from 2025 levels.

Within the digital health segment, RadNet anticipates revenue growth between 45% and 55% in 2026, driven by sales of AI-powered workflow solutions and contributions from recent acquisitions. Notably, the company introduced a new metric, Annual Recurring Revenue (ARR), which is expected to reach approximately $140 million by the end of 2026, marking a significant milestone for its digital health business.

RadNet's focus on acquiring cutting-edge AI solutions, such as Gleamer, is expected to yield substantial operational efficiencies and further boost its market position. The integration of Gleamer's technology is anticipated to improve productivity and streamline workflows, ultimately enhancing patient outcomes and satisfaction.

Conclusion

In summary, RadNet's fourth quarter and full year 2025 results reflect strong financial performance fueled by strategic growth initiatives and operational efficiencies. The successful acquisition of Gleamer positions the company as a leader in the radiology AI space, promising to transform the workflow and clinical capabilities within radiology. With a solid financial foundation and a clear growth strategy, RadNet is poised to continue its upward trajectory in the evolving healthcare landscape, making significant advancements in imaging services and digital health solutions. Investors can look forward to the company's ongoing commitment to innovation and excellence in patient care.